The global electrophysiology mapping and ablation devices market was valued at USD 25.07 billion in 2024 and is projected to expand at a CAGR of 8.93% between 2025 and 2034, driven by increasing prevalence of cardiac arrhythmias, wider adoption of catheter-based therapies, and strong demand across distinct product and application segments. As healthcare providers aim to improve treatment...